Mach-1 Financial Group »

Crispr Therapeutics shares owned by Mach-1 Financial Group

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mach-1 Financial Group from 13F filings

Historical chart of Mach-1 Financial Group investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Mach-1 Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Mach-1 Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $441k 7.0k 62.60

More positions owned by Mach-1 Financial Group

First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
First Tr Exchng Traded Fd Vi Cboe Vest Us Eq (BUFR)
Wal-Mart Stores (WMT)
Spdr Index Shs Fds Msci Acwi Exus (CWI)
Microsoft Corporation (MSFT)
First Tr Value Line Divid In SHS (FVD)
First Tr Exchange-traded Ft Cboe Vest S&p (KNG)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
First Tr Morningstar Divid L SHS (FDL)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
JPMorgan Chase & Co. (JPM)
Wells Fargo & Company (WFC)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)

View all positions for Mach-1 Financial Group

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics